SUBSCRIPTION AGREEMENTSubscription Agreement • February 2nd, 2012 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
THIS SUBSCRIPTION AGREEMENT is made and effective as of January 27, 2012 (the “Effective Date”) by and between Accentia Biopharmaceuticals, Inc., a Florida corporation with a place of business located at 324 South Hyde Park Avenue, Suite 350, Tampa, FL 33606 (the “Company” or “Accentia”), and REF HOLDINGS, LLC, with an address of 801 North 500 West, Suite 200, Bountiful, UT 84010 (“Subscriber”), as follows:
COMMON STOCK PURCHASE WARRANT ACCENTIA BIOPHARMACEUTICALS, INC.Accentia Biopharmaceuticals Inc • February 2nd, 2012 • Pharmaceutical preparations • Florida
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, REF HOLDINGS, LLC (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time commencing on the Issue Date and ending on the close of business on the five (5) year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”), up to FIVE HUNDRED EIGHTY-SIX THOUSAND FIVE HUNDRED ELEVEN [586,511] shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
